Pilot trial to prevent type I diabetes: progression to overt IDDM despite oral nicotinamide.
Autor: | Herskowitz RD; Joslin Diabetes Center, Brigham and Women's Hospital, Boston, Massachusetts., Jackson RA, Soeldner JS, Eisenbarth GS |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of autoimmunity [J Autoimmun] 1989 Oct; Vol. 2 (5), pp. 733-7. |
DOI: | 10.1016/s0896-8411(89)80011-3 |
Databáze: | MEDLINE |
Externí odkaz: |